​

Zimmer Biomet (ZBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZBH Stock Forecast

Zimmer Biomet (ZBH) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $92.86, with a high of $105.00 and a low of $83.00. This represents a 1.65% increase from the last price of $91.35.

$80 $91 $102 $113 $124 $135 High: $105 Avg: $92.86 Low: $83 Last Closed Price: $91.35

ZBH Stock Rating

Zimmer Biomet stock's rating consensus is Hold, based on 42 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (40.48%), 22 Hold (52.38%), 3 Sell (7.14%), and 0 Strong Sell (0.00%).

Hold
Total 42 3 22 17 0 Strong Sell Sell Hold Buy Strong Buy

ZBH Price Target Upside V Benchmarks

TypeNameUpside
StockZimmer Biomet1.65%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks30.52%

Price Target Trends

1M3M12M
# Anlaysts1621
Avg Price Target$95.00$93.50$102.48
Last Closing Price$91.35$91.35$91.35
Upside/Downside4.00%2.35%12.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2626171-26
Jun, 2626171-26
May, 2626171127
Apr, 2626171127
Mar, 2636172129
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 08, 2026BMO Capital$95.00$87.568.50%4.00%
Apr 29, 2026Truist Financial$92.00$80.8013.86%0.71%
Apr 29, 2026Canaccord Genuity$83.00$82.800.24%-9.14%
Apr 29, 2026Rick WiseStifel Nicolaus$105.00$82.8026.81%14.94%
Apr 29, 2026Robert W. Baird$92.00$82.8011.11%0.71%
Apr 29, 2026Matt MiksicBarclays$94.00$82.8013.53%2.90%
Feb 12, 2026Matt MiksicBarclays$100.00$96.693.42%9.47%
Feb 11, 2026UBS$89.00$93.69-5.01%-2.57%
Jan 28, 2026UBS$86.00$85.270.86%-5.86%
Jan 09, 2026Bernstein$99.00$94.085.23%8.37%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 08, 2026BMO CapitalMarket Performinitialise
Apr 29, 2026CitigroupNeutralNeutralhold
Apr 29, 2026BarclaysUnderweightUnderweighthold
Feb 20, 2026William BlairBuyMarket Performinitialise
Feb 12, 2026BarclaysUnderweightUnderweighthold
Feb 11, 2026UBSSellSellhold
Feb 11, 2026CitigroupBuyBuyhold
Jan 26, 2026Cowen & Co.HoldBuyupgrade
Jan 09, 2026BernsteinMarket PerformMarket Performhold
Jan 09, 2026Goldman SachsBuySelldowngrade

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.93$1.10$4.91$4.45$3.56---
Avg Forecast$7.17$6.84$7.51$7.98$8.56$9.24$9.99$10.61
High Forecast$7.28$6.90$7.57$8.01$8.82$11.87$10.76$10.73
Low Forecast$7.08$6.75$7.23$7.94$8.44$7.18$9.22$10.43
Surprise %-73.08%-83.92%-34.62%-44.24%-58.41%---

Revenue Forecast

$7B $7B $8B $8B $9B $10B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.83B$6.94B$7.39B$7.68B$8.23B---
Avg Forecast$7.86B$6.87B$7.38B$7.67B$8.01B$8.38B$8.78B$9.19B
High Forecast$7.95B$6.92B$7.43B$7.68B$8.08B$8.38B$8.81B$9.27B
Low Forecast$7.79B$6.80B$7.24B$7.66B$7.92B$8.37B$8.76B$9.07B
Surprise %-13.16%0.95%0.16%0.11%2.76%---

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$401.60M$231.40M$1.02B$903.80M$705.20M---
Avg Forecast$368.25M$224.98M$1.02B$1.67B$1.81B$2.00B$2.10B$2.22B
High Forecast$475.67M$307.13M$1.40B$1.68B$1.85B$2.49B$2.26B$2.25B
Low Forecast$260.83M$142.84M$651.48M$1.67B$1.77B$1.50B$1.93B$2.19B
Surprise %9.06%2.85%--45.98%-61.04%---

ZBH Forecast FAQ

Is Zimmer Biomet stock a buy?

Zimmer Biomet stock has a consensus rating of Hold, based on 42 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 22 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Zimmer Biomet is a neutral investment for most analysts.

What is Zimmer Biomet's price target?

Zimmer Biomet's price target, set by 42 Wall Street analysts, averages $92.86 over the next 12 months. The price target range spans from $83 at the low end to $105 at the high end, suggesting a potential 1.65% change from the previous closing price of $91.35.

How does Zimmer Biomet stock forecast compare to its benchmarks?

Zimmer Biomet's stock forecast shows a 1.65% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (30.52%).

What is the breakdown of analyst ratings for Zimmer Biomet over the past three months?

  • July 2026: 7.69% Strong Buy, 23.08% Buy, 65.38% Hold, 3.85% Sell, 0% Strong Sell.
  • June 2026: 7.69% Strong Buy, 23.08% Buy, 65.38% Hold, 3.85% Sell, 0% Strong Sell.
  • May 2026: 7.41% Strong Buy, 22.22% Buy, 62.96% Hold, 3.70% Sell, 3.70% Strong Sell.

What is Zimmer Biomet’s EPS forecast?

Zimmer Biomet's average annual EPS forecast for its fiscal year ending in December 2026 is $9.24, marking a 159.55% increase from the reported $3.56 in 2025. Estimates for the following years are $9.99 in 2027, and $10.61 in 2028.

What is Zimmer Biomet’s revenue forecast?

Zimmer Biomet's average annual revenue forecast for its fiscal year ending in December 2026 is $8.38B, reflecting a 1.78% increase from the reported $8.23B in 2025. The forecast for 2027 is $8.78B, and $9.19B for 2028.

What is Zimmer Biomet’s net income forecast?

Zimmer Biomet's net income forecast for the fiscal year ending in December 2026 stands at $2B, representing an 183.23% increase from the reported $705.2M in 2025. Projections indicate $2.1B in 2027, and $2.22B in 2028.